Published in Women's Health Weekly, December 2nd, 2010
"We thus considered that apocrine metaplasia (AM) might represent a predictive marker for breast cancer. A total of 210 primary invasive breast cancers from Japanese patients were scored according to the size of cytoplasmic granules and abundance of cytoplasm, then classified into three categories:...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly